Stay updated on Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe footer revision label updated from v3.6.2 to v3.6.3, signaling a minor site update to the page rendering without changing study information.SummaryDifference0.1%

- Check19 days agoChange DetectedThe footer revision label changed from v3.6.0 to v3.6.2, signaling a backend/UI version update.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now shows recruitment closed ('No longer looking for participants') and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment header and updates the page revision to v3.6.0.SummaryDifference0.6%

- Check41 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 to reflect the current version of the page content. This appears to be a minor administrative update without altering substantive content or functionality.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, indicating a small backend/site update without changes to the study content.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page's revision tag updated to v3.5.3 (replacing v3.5.2), and certain related topics entries, including Prostate cancer and MedlinePlus Genetics, were removed from the related topics list.SummaryDifference0.2%

Stay in the know with updates to Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.